Research programme: human papillomavirus vaccine - National Institute of Infectious Diseases (Japan)/KM Biologics
Alternative Names: Human papillomavirus (HPV) vaccine - National Institute of Infectious Diseases (NIID)/KM Biologics; Kanda HPV vaccineLatest Information Update: 06 Nov 2018
At a glance
- Originator National Institute of Infectious Diseases
- Class Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cervical cancer; Human papillomavirus infections
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Cervical-cancer(Prevention) in Japan (Parenteral)
- 04 Nov 2017 No recent reports of development identified for preclinical development in Human-papillomavirus-infections in Japan (Parenteral)
- 10 Mar 2015 Preclinical development is ongoing in Japan